| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.8M | +475.5% |
| Cost of Revenue | $20.4M | +703.4% |
| Gross Profit | $3.4M | +112.9% |
| R&D Expense | $12.4M | +293.7% |
| SG&A Expense | $2.6M | -89.5% |
| Operating Income | -$59.9M | -127.3% |
| Interest Expense | $9K | -47.5% |
| Pre-tax Income | -$159.6M | -393.8% |
| Income Tax | $282K | +153.0% |
| Net Income | -$159.8M | -393.0% |
| EPS (Basic) | -$2.11 | -234.9% |
| EPS (Diluted) | -$2.11 | -234.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $285.6M | +361.4% |
| Short-term Investments | $47.7M | — |
| Inventory | $1.1M | +1572.4% |
| Current Assets | $399.9M | +508.3% |
| Total Assets | $498.0M | +427.9% |
| Current Liabilities | $32.7M | +363.2% |
| Long-term Debt | $14.4M | +503.1% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.8M | -126.3% |
| Capital Expenditures | $9.7M | -0.2% |
| Investing Cash Flow | -$110.8M | -874.2% |
| Financing Cash Flow | $371.6M | +350.2% |
| Free Cash Flow | -$47.4M | -79.9% |
| $235.1M |
| +444.5% |
| Stockholders' Equity | $204.2M | +326.2% |